Verastem Oncology Presents Further COPIKTRA (Duvelisib) Data at the 23rd Annual International Congress on Hematologic Malignancies
BOSTON--(BUSINESS WIRE)--Mar 7, 2019--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicin…
